Form 8-K - Current report:
SEC Accession No. 0001628280-24-005061
Filing Date
2024-02-15
Accepted
2024-02-15 16:20:39
Documents
14
Period of Report
2024-02-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K arqt-20240212.htm   iXBRL 8-K 30311
  Complete submission text file 0001628280-24-005061.txt   159734

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20240212.xsd EX-101.SCH 1889
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20240212_lab.xml EX-101.LAB 24851
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20240212_pre.xml EX-101.PRE 13038
15 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20240212_htm.xml XML 2835
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

EIN.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39186 | Film No.: 24644089
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)